Danaher | DHR - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.6B 330M 2026-06
Agilent USD 465M 11M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Boston Scientific USD 1.78B 53M 2026-03
Bruker USD 242.1M 5.1M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 351M 32M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
ESCO Technologies USD 61.21M 2.13M 2025-12
Fortive USD 417.3M 100K 2026-03
Henry Schein USD 809M 1000K 2026-03
Illumina USD 272M 11M 2026-03
Intuitive Surgical USD 617.9M 4.6M 2026-06
IQVIA Holdings USD 502M 34M 2026-03
Keysight Technologies USD 456M 9M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Medtronic 2.96B 9M 2025-12
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Quidel USD 199.3M 4.9M 2026-03
Repligen USD 76.54M 2.17M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Roper Industries USD 884.2M 42.6M 2026-03
Stryker USD 2.15B 17M 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Waters USD 394M 153.99M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03